apl. Prof. Dr. med. Klaus Golka

Academic background

• 07/06 apl.-Prof. at the Ruhr-University Bochum
• 10/99 Thesis for habilitation at the Ruhr-University Bochum for "Occupational Medicine"
• 2/95 Certified for environmental medicine
• 9/89 Specialist in occupational medicine
• 8/87 Postdoctoral research fellow at the IfADo Research Centre for Working Environment and Human Factors
• 1/86 Degree to Dr. med., Justus-Liebig-University Gießen
• 9/84-7/87 Residency, Hospital for Psychosomatic and Internal Medicine "Am Hasenbach", Clausthal-Zellerfeld
• 2/83-5/84 Residency in internal medicine, Hospital of the County of Gießen, Academic Teaching Hospital, Justus-Liebig-University Gießen
• 11/82 Medical doctor
• 10/76-10/82 Study of human medicine at the Justus-Liebig-University Gießen, Germany

Research interests

• Occupational and non-occupational causes of cancer of the urogenital tract and the impact of xenobiotic metabolising enzymes and ethnicity

Current research

• central support unit "Clinical Occupational Medicine"
• research group "Individual Susceptibility to Dangerous Chemicals"

Selected publications

• Golka, K., Prior, V., Blaszkewicz, M., Cascorbi, I., Schöps, W., Kierfeld, G., Roots, I., Bolt, H.M.: Occupational history and genetic N-acetyl¬transferase polymorphism in urothelial cancer patients of Leverkusen, Germany. Scand. J. Work Environ. Health 22, 332-338 (1996)
• Golka, K., Bandel, T., Schlaefke, S., Reich, S.E., Reckwitz, T., Urfer, W., Bremicker, K.-D., Neugebauer, W., Soekeland, J., Bolt, H.M.: Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: a case-control study. Int. J. Occup. Environ. Health 4, 79-84 (1998)
• Golka, K., Roth, E., Huber, J., Schmitt, K.: Reversible ageusia as an effect of clopidogrel treatment. Lancet 355, 465-466 (2000)
• Golka, K., Prior, V., Blaszkewicz, M., Bolt, H.M.: The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicol. Lett. 128, 229-241 (2002)
• Golka, K., Wiese, A.: Carbohydrate-deficient transferrin (CDT) - a long-term biomarker for alcohol consumption. J. Toxicol. Environ. Health Part B Crit. Rev. 7 319-337 (2004)
• Kiemeney L.A., Thorlacius S., Sulem P., Geller F., Aben K.K., Stacey S.N., Gudmundsson J., Jakobsdottir M., Bergthorsson J.T., Sigurdsson A., Blondal T., J. Witjes J.A., Vermeulen S.H., Hulsbergen-van de Kaa C.A., Swinkels D.W., Ploeg M., Cornel E.B., Vergunst H., Thorgeirsson T. E., Gudbjartsson D., Gudjonsson S.A., Thorleifsson G., Kristinsson K.T., Mouy M., Snorradottir S., Placidi D., Campagna M., Arici C., Koppova K., Gurzau E., Rudnai P., Kellen E., Polidoro P., Guarrera S., Sacerdote C., Sanchez M., Saez B., Valdivia G., Ryk C., de Verdier P., Lindblom A., Golka K, Bishop D.T., Knowles M.A., Nikulasson S., Petursdottir V., Jonsson E., Geirsson G., Kristjansson B., Mayordomo J.I., Steineck G., Porru S., Buntinx F., Zeegers M.P., Fletcher T., Kumar R., Matullo G., Vineis P., Kiltie A.E., Gulcher J.R., Thorsteinsdottir U., Kong A., Rafnar T., Stefansson K.: Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 40, 1307-1312 (2008)
• Golka K., Hermes M., Selinski S., Blaszkewicz M., Bolt H.M., Roth G., Dietrich H., Prager H.M., Ickstadt K., Hengstler J.G.: Susceptibility to urinary bladder cancer: Relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogenet. Genomics 19, 903-906 (2009)
• Golka K., Selinski S., Lehmann M.L., Blaszkewicz B., Marchan R., Ickstadt K., Schwender H., Bolt H.M., Hengstler J.G. (2011) Genetic variants in urinary bladder cancer: collective power of the “wimp SNPs”. Arch. Toxicol. 85, 539-554 (2011)

Neumitglied in International Editorial Board